Sarver Vrooman Wealth Advisors’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDW
HCM
IF
WCM
SCM
PWM
ATC
WPW
QFA
MW
SWM
Sarver Vrooman Wealth Advisors's IBDW Position: Q2 2026 in Review
Sarver Vrooman Wealth Advisors increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 1.2% in Q2 2026, buying an estimated $549K and bringing the position to 2,220,499 shares worth $46.1M. The position accounts for 27.48% of the portfolio, ranked #2.
Sarver Vrooman Wealth Advisors first reported a position in IBDW in Q1 2025 and has held it in 6 quarters since. The position peaked at $46.3M in Q3 2025. 52 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.
- Sarver Vrooman Wealth Advisors held 2,220,499 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $46.1M as of Q2 2026.
- Sarver Vrooman Wealth Advisors bought 26,318 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $549K.
- iShares iBonds Dec 2031 Term Corporate ETF made up 27.48% of Sarver Vrooman Wealth Advisors's portfolio in Q2 2026, its #2 holding.
- Sarver Vrooman Wealth Advisors first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
- Sarver Vrooman Wealth Advisors's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $46.3M in Q3 2025.
- 52 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.
Based on Sarver Vrooman Wealth Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.